Newsmeme!
Discover News you didn't know existed
Adenocarcinoma
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Cell Pathway May Be Key to Lung Cancer's Spread
Published July 3, 2009, 7:49 pm, HealthCentral
Researchers express hope that finding will lead to treatments.
Cell Pathway May Be Key to Lung Cancer's Spread
Published July 3, 2009, 6:53 am, ABC 7 El Paso
By Peter West , HealthDay Reporter FRIDAY, July 3 (HealthDay News) -- U.S. researchers say they've found a major cellular flaw that may drive the rapid spread of...
Cell Pathway May Be Key to Lung Cancer's Spread
Published July 3, 2009, 6:47 am, KTVN Reno
FRIDAY, July 3 (HealthDay News) -- U.S. researchers say they've found a major cellular flaw that may drive the rapid spread of relapsed lung cancer. When caught early, lung cancer can often be treated. But most cases are not detected until the disease is well advanced.
Cell Pathway May Be Key to Lung Cancer's Spread
Published July 3, 2009, 6:02 am, HealthDay via Yahoo! News
FRIDAY, July 3 (HealthDay News) -- U.S. researchers say they've found a major cellular flaw that may drive the rapid spread of relapsed lung cancer.
Pfizer drug slows progression of a type of pancreatic cancer
Published July 2, 2009, 9:46 am, CancerFacts.com
BARCELONA – July 1, 2009 – Patients treated with Sutent® for a form of pancreatic cancer survived without the disease progressing for an average of 6 months longer than patients not treated, according to a study presented today at the 11th World Congress on Gastrointestinal Cancer.
Gefitinib Receives European Licence For The Treatment Of Lung Cancer For Patients With EGFR Activating Mutation ...
Published July 2, 2009, 6:23 am, Medical News Today
AstraZeneca announced that it has received a licence by the European Medicines Agency (EMEA) for its oral targeted anti-cancer drug, gefitinib, for EGFR (epidermal growth factor receptor-tyrosine kinase) activating mutation positive patients with Non Small Cell Lung Cancer (NSCLC). NSCLC is the most common type of lung cancer and accounts for 80% of all lung cancer cases.
Sutent Significantly Improved Progression-Free Survival For Patients With Advanced Pancreatic Islet Cell Tumours
Published July 1, 2009, 4:08 am, Medical News Today
Pfizer announced preliminary results from a randomized Phase 3 trial of Sutent (sunitinib malate) in patients with advanced pancreatic islet cell tumours, also known as pancreatic neuroendocrine tumours, which is a different type of cancer than the more common pancreatic adenocarcinoma. Study findings demonstrated that median progression-free survival (PFS) was 11.
Peptic ulcer bacterium alters the body's defence system
Published June 30, 2009, 12:42 am, News-Medical-Net
Helicobacter pylori survives in the body by manipulating important immune system cells. This is shown in a thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden. The discovery may lead to new treatments against the common peptic ulcer bacterium.
Pancreatic cancer
Published June 29, 2009, 8:56 pm, Australian Broadcasting Corporation
Pancreatic cancer is one of the deadliest tumours and causes a disproportionate number of deaths in Australia
Cancer Hits Close to Home
Published June 29, 2009, 3:55 pm, 2News Salt Lake City
Pancreatic cancer is often called a silent killer because symptoms usually don’t surface until the cancer is in its late stages.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |